HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: fj.07-9814v1 fj.07-9814v2 22/4/1083    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Roze, E. Articles by Caboche, J. Search for Related Content PubMed PubMed Citation Articles by Roze, E. Articles by Caboche, J.

Mitogen- and stress-activated protein kinase-1 deficiency is involved in expanded-huntingtin-induced transcriptional dysregulation and striatal death

Emmanuel Roze^*,, Sandrine Betuing^*, Carole Deyts^*, Estelle Marcon^*, Karen Brami-Cherrier, Christiane Pagès^*, Sandrine Humbert, Karine Mérienne^|| and Jocelyne Caboche^*,1

^* Université Pierre et Marie Curie-Paris 6, CNRS, UMR 7102, Paris, France;

Service de Neurologie, Hôpital Saint-Antoine, Assitance Publique-Hôpitaux de Paris, Paris, France;

Université Pierre et Marie Curie-Paris 6, INSERM, UMRS 839, Paris, France;

Institut Curie, CNRS, UMR 146,Orsay, France; and

^|| Institut de Génétique et de Biologie Moléculaire et Cellulaire, Département de pathologie moléculaire; INSERM, U596; CNRS, UMR 7104, Illkirch, France

¹Correspondence: Université Pierre et Marie Curie-Paris 6, CNRS, UMR 7102, 9 quai St. Bernard, 75005, Paris, France. E-mail: jocelyne.caboche{at}snv.jussieu.fr

Huntington’s disease (HD) is a neurodegenerative disorder due to an abnormal polyglutamine expansion in the N-terminal region of huntingtin protein (Exp-Htt). This expansion causes protein aggregation and neuronal dysfunction and death. Transcriptional dysregulation due to Exp-Htt participates in neuronal death in HD. Here, using the R6/2 transgenic mouse model of HD, we identified a new molecular alteration that could account for gene dysregulation in these mice. Despite a nuclear activation of the mitogen-activated protein kinase/extracellular regulated kinase (ERK) along with Elk-1 and cAMP responsive element binding, two transcription factors involved in c-Fos transcription, we failed to detect any histone H3 phosphorylation, which is expected after nuclear ERK activation. Accordingly, we found in the striatum of these mice a deficiency of mitogen- and stress-activated kinase-1 (MSK-1), a kinase downstream ERK, critically involved in H3 phosphorylation and c-Fos induction. We extended this observation to Exp-Htt-expressing striatal neurons and postmortem brains of HD patients. In vitro, knocking out MSK-1 expression potentiated Exp-Htt-induced striatal death. Its overexpression induced H3 phosphorylation and c-Fos expression and totally protected against striatal neurodegeneration induced by Exp-Htt. We propose that MSK-1 deficiency is involved in transcriptional dysregulation and striatal degeneration. Restoration of its expression and activity may be a new therapeutic target in HD.— Roze, E., Betuing, S., Deyts, C., Marcon, E., Brami-Cherrier, K., Pagès, C., Humbert, S., Mérienne, K., Caboche, J. Mitogen- and stress-activated protein kinase-1 deficiency is involved in expanded-huntingtin-induced transcriptional dysregulation and striatal death.

Key Words: Huntington’s disease • polyglutamine • histone modifications • nucleosomal response • c-Fos